VolitionRx Completes $2 Million Funding Round With Significant Investor Partnership VolitionRx Limited has successfully secured $2 million in funding through an amended securities purchase agreement with Lind Global Asset Management.

VolitionRx Completes $2 Million Funding Round With Significant Investor Partnership #United_States #Henderson #VolitionRx #epigenetics #Lind_Global_Asset_Management